INCOG BioPharma Services, an Indiana-based contract development and manufacturing organization (CDMO) specializing in sterile injectables, recently opened its doors to the public to showcase the company’s state-of-the-art biomanufacturing facility during a grand opening ceremony on Thursday, May 19th.

As guests gathered outside the new 90,000 sq. ft. facility, INCOG CEO and founder Cory Lewis said, “Achieving this milestone has been two years in the making for our business and our team. Alongside the installation of our filling line, we’ll now prepare for GMP readiness activities that will ultimately contribute to supporting biopharmaceutical customers with sterile injectable filling. We are pleased to celebrate this moment with our employees and the many external team members who were involved with the construction and readiness of our site and building.”

Guests were able to experience a behind-the-scenes tour of the fill-finish manufacturing facility, meet the team, and learn about drug product handling processes before the organization finalizes the cleanroom areas for production-readiness activities. The facility formulates and fills injectable drugs into vials, syringes and cartridges.

INCOG has capacity to quickly ramp up to deliver solutions for clients looking for a cohesive drug product solution. Laboratory and technical services offered by INCOG include formulations and analytical development for clinical and commercial scale-up, with the goal of accelerating clinical trials and drug availability in the market. INCOG provides in-house quality control, stability, and chemistry and microbiology testing services.